Cell-Free DNA (cfDNA) Testing Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type ( donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA), cell-free fetal DNA (NIPT) ); Application ( oncology, gynecology, transplantation )
Cell-Free DNA are fragments of DNA that circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which a small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients, and detect various chromosomal abnormalities in the fetus to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation, and infectious diseases.
The cell-free DNA (cfDNA) testing market is driving due to the Increased incidences of diseases like chromosomal abnormalities due to increase in maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer. However, lack of standardization, unfavorable reimbursement policies and legal and regulatory guidelines some of the reasons hampering the growth of the market. Moreover, increasing healthcare expenditure and rising healthcare awareness are driving the cell-free DNA market.
The "Cell-Free DNA (cfDNA) Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell-free DNA (cfDNA) testing market with detailed market segmentation by type and application. The cell-free DNA (cfDNA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell-free DNA (cfDNA) testing market and offers key trends and opportunities in the market.
The cell-free DNA (cfDNA) testing market is segmented on the basis of type and application. Based on type, the market is segmented as donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA) and cell-free fetal DNA (NIPT). On the basis of application, the market is categorized as oncology, gynecology and transplantation.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell-free DNA (cfDNA) testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell-free DNA (cfDNA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cell-free DNA (cfDNA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell-free DNA (cfDNA) testing market in these regions.
Get more information on this report :
The report covers key developments in the cell-free DNA (cfDNA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell-free DNA (cfDNA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell-free DNA (cfDNA) testing in the global market. Below mentioned is the list of few companies engaged in the cell-free DNA (cfDNA) testing market.
The report also includes the profiles of key players in cell-free DNA (cfDNA) testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Guardant Health, Inc.
Inivated Limited, Natera, Inc.
Roche Holdings AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. Agilent Technology
2. Allenex AB
3. Biocept, Inc.
4. Biodesix, Inc.
5. CareDx, Inc.
6. Guardant Health, Inc.
7. Illumania, Inc.
8. Inivated Limited, Natera, Inc.
9. Quest Diagnostics
10. Roche Holdings AG
11. Sequenom, Inc.